Jove
Visualize
Contact Us

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

900
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
900
Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recombinant Human Nerve Growth Factor in Pediatric Neuropathic Keratopathy: A Focus on Corneal Opacities, Amblyopia, and Visual Outcomes.

Cornea·2026
Same author

Treatment of increased intracranial pressure secondary to otitic hydrocephalus.

Frontiers in pediatrics·2026
Same author

Update on Pediatric Idiopathic Intracranial Hypertension.

International ophthalmology clinics·2026
Same author

Premature Closure: A Surprising Case of Papilledema.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

The Rates of Retinal Nerve Fiber Layer Change in Children With Optic Disc Drusen.

Ophthalmology science·2026
Same author

Visual Outcomes of Plasma Exchange for Acute Optic Neuritis: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 27, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.4K

Update on Pediatric Optic Neuritis.

Ryan A Gise1,2, Gena Heidary3,4

  • 1Department of Ophthalmology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA, 02115, USA.

Current Neurology and Neuroscience Reports
|March 4, 2020
PubMed
Summary

Advances in pediatric demyelinating optic neuritis reveal distinct disease phenotypes. Identifying specific causes, like myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease, is crucial for effective treatment and prognosis.

Keywords:
Chronic relapsing inflammatory optic neuropathyDemyelinating diseaseMyelin oligodendrocyte glycoproteinNeuromyelitis opticaPediatric optic neuritis

More Related Videos

Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

10.1K
A Surgical Approach for Optic Nerve Crush in a Rabbit Model
06:15

A Surgical Approach for Optic Nerve Crush in a Rabbit Model

Published on: July 8, 2025

1.1K

Related Experiment Videos

Last Updated: Dec 27, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.4K
Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

10.1K
A Surgical Approach for Optic Nerve Crush in a Rabbit Model
06:15

A Surgical Approach for Optic Nerve Crush in a Rabbit Model

Published on: July 8, 2025

1.1K

Area of Science:

  • Ophthalmology
  • Neurology
  • Pediatrics

Background:

  • Pediatric demyelinating optic neuritis phenotypes have been clarified over the last decade.
  • Optic neuritis in children can be isolated or part of broader neurological conditions.
  • Distinguishing between causes like multiple sclerosis, neuromyelitis optica, and MOG IgG is essential.

Purpose of the Study:

  • To update on advancements in understanding pediatric demyelinating optic neuritis.
  • To highlight the expanded disease phenotypes in pediatric demyelinating optic neuritis.
  • To emphasize the importance of accurate diagnosis for treatment and prognosis.

Main Methods:

  • Review of recent literature on pediatric demyelinating optic neuritis.
  • Analysis of clinical presentations and diagnostic criteria.
  • Evaluation of treatment strategies and prognostic indicators.

Main Results:

  • Defined distinct disease phenotypes for pediatric demyelinating syndromes.
  • Identified myelin oligodendrocyte glycoprotein (MOG IgG) as a unique cause with specific characteristics.
  • Recognized variability in treatment effectiveness across different causes.

Conclusions:

  • Accurate differentiation of pediatric demyelinating optic neuritis subtypes is critical.
  • Timely and precise diagnosis guides appropriate treatment to prevent disability.
  • Understanding specific etiologies improves visual outcome predictions and long-term prognosis.